Suchergebnisse - "Nicolini, Franck E"

PubPharm (130)

1

Chronic myeloid leukemia diagnosed in pregnancy : management and outcome of 87 patients reported to the European LeukemiaNet international registry

enthalten in: Leukemia | 2024

von Chelysheva, E. | Apperley, J. | Turkina, A. | +16

2

Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes : A nationwide CEREO study

enthalten in: American journal of hematology | 2024

von Groh, M. | Fenwarth, L. | Labro, M. | +40

3

Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients

enthalten in: British journal of haematology | 2024

von Alcazer, V. | Morisset, S. | Rea, D. | +8

4

Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

enthalten in: Leukemia | 2024

von Brioli, A. | Lomaia, E. | Fabisch, C. | +35

5

Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?

enthalten in: Leukemia | 2024

von Kantarjian, H. | Branford, S. | Breccia, M. | +9

6

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia : Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mahon, F. | Pfirrmann, M. | Dulucq, S. | +65

7

Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies : Long-term results from a real-life study

enthalten in: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2024

von Michallet, M. | Sobh, M. | Deloire, A. | +7

8

Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation : Final analysis of the TFR-PRO study

enthalten in: American journal of hematology | 2023

von Zambrotta, G. | Nicolini, F. | Assouline, S. | +25

9

Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation : final analysis of the TFR-PRO study

enthalten in: American journal of hematology | November 2023

von Zambrotta, G. | Nicolini, F. | Assouline, S. | +25

10

Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia : Results of a multicenter phase 2 study (DASA-PegIFN study)

enthalten in: British journal of haematology | 2023

von Roy, L. | Chomel, J. | Guilhot, J. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]